BioLineRx Ltd. (BLRX)
NASDAQ: BLRX · Real-Time Price · USD
0.203
+0.001 (0.50%)
At close: Dec 20, 2024, 4:00 PM
0.208
+0.005 (2.66%)
After-hours: Dec 20, 2024, 6:31 PM EST
BioLineRx Market Cap
BioLineRx has a market cap or net worth of $19.08 million as of December 20, 2024. Its market cap has decreased by -82.89% in one year.
Market Cap
19.08M
Enterprise Value
19.53M
1-Year Change
-82.89%
Ranking
Category
Stock Price
$0.20
Market Cap Chart
Since July 27, 2009, BioLineRx's market cap has decreased from $33.80M to $19.08M, a decrease of -43.55%. That is a compound annual growth rate of -3.64%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Affimed | 19.51M |
| Concord Medical Services Holdings | 19.17M |
| Retractable Technologies | 19.16M |
| Bolt Biotherapeutics | 19.14M |
| Tenax Therapeutics | 19.12M |
| Palatin Technologies | 18.92M |
| CervoMed | 18.41M |
| Alterity Therapeutics | 18.30M |